Who owns KIM DENNIS D?

No ownership or control links for KIM DENNIS D are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is KIM DENNIS D's risk level?

WhiteIntel flags KIM DENNIS D as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does KIM DENNIS D appear across sources?

KIM DENNIS D is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

SnitchScore · reading…

evidence coverage · reading…

Legal entityLow

KIM DENNIS D

Name: KIM DENNIS D — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, KIM DENNIS D, Company, US

KIM DENNIS D — US company (sec:0001456750). 4 holdings. Every claim linked to its source.

SEC 0001456750CompanyUS

Ownership graph Export .md

JSON / MCPsample

/01

Ownership & control

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Owners / controllers

None in current sources.

Holdings / subsidiaries

KIM DENNIS D
- CYMABAY THERAPEUTICS, INC.· officer· via SEC EDGAR
- Skye Bioscience, Inc.· officer· via SEC EDGAR
- Larimar Therapeutics, Inc.· officer· via SEC EDGAR
- OREXIGEN THERAPEUTICS, INC.· officer· via SEC EDGAR

Nothing further is withheld here. The ownership and control links above are everything we have resolved for KIM DENNIS D — there is no deeper chain behind a paywall. Absence means “not observed in our current sources” — it is not a finding of none.

Monitoring

Coverage of KIM DENNIS D is still thin in the current sources. Watch it and we'll flag the moment new ownership, filings or risk signals land.

Explore US coverage

WHAT YOU CAN SEEFREE

YOURS NOW · FREE

4 items you can read right now — no account, no payment.

Identity, address & registry profile
Sanctions & watchlist detail
Direct connections (1 hop)
Community notes

Nothing further on KIM DENNIS D is behind a paywall — everything we hold on this subject is already on this page.

/02

People & control

4 parties · 0 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

●
CYMABAY THERAPEUTICS, INC.
Also holds roles at 38 other companies
- LOEWY CAROLINE Mdirector
- Shantharam Harishofficer
- EMSTER KURT VONdirector
●
Larimar Therapeutics, Inc.
Also holds roles at 83 other companies
- Shankar Gopiofficer
- Clayton Russellofficer
- BEN-MAIMON CAROLEofficer
●
OREXIGEN THERAPEUTICS, INC.
Also holds roles at 70 other companies
- KLARMAN SETH Atenpercentowner
- BAUPOST GROUP GP, L.L.C.tenpercentowner
- BAUPOST GROUP LLC/MAtenpercentowner
●
Skye Bioscience, Inc.
Also holds roles at 57 other companies
- ARSENAULT KAITLYNofficer
- Schwab Andrew J.director
- Jenkins Annalisadirector

4 parties · 0 current. Ceased and resigned records are retained as history.

/03

Common questions

Who owns KIM DENNIS D?: No ownership or control links for KIM DENNIS D are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.
What is KIM DENNIS D's risk level?: WhiteIntel flags KIM DENNIS D as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.
Where does KIM DENNIS D appear across sources?: KIM DENNIS D is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on KIM DENNIS D. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Loading tips…